#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Raynaud's phenomenon Inflammatory myofibroblastic tumour Deafness Orthostatic hypotension Gastrooesophageal cancer Ureteric cancer Amyotrophic lateral sclerosis gene carrier Thymic carcinoma Congenital aplastic anaemia Urea cycle disorder Hereditary neuropathic amyloidosis Carcinoid tumour Optic glioma Cholangiosarcoma Pouchitis More trials…

    Learn about Rare Diseases

    Combined immunodeficiency – Treatment Waldenstrom’s macroglobulinaemia recurrent – Basic Information Rett syndrome Myelodysplastic syndrome with excess blasts – Trials in Disease Langerhans’ cell histiocytosis Retinoblastoma – Life with Disease Breast angiosarcoma metastatic Thrombotic thrombocytopenic purpura – Basic Information Friedreich’s ataxia – Diagnostics Hairy cell leukaemia More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    10-1074-Ls SURVODUTIDE Olive Oil, Refined Opevesostat Tosilate Abc-23B-116 Sot102 Bt8009 Perflutren ALG-000184 HYDROMORPHONE HYDROCHLORIDE Mk-2060 Specific Nucleic Acid Sna-Xfsa Sodium Hydrogen Carbonate Paracetamol Ph. Eur. Rineterkib Rtx001 Purified Egg Phospholipids Betahistine Dihydrochloride ADS-019 Dronedarone More therapies…

    Learn about Your Condition

    Cardiac arrest Cholangiosarcoma Binge eating Diarrhoea Rectosigmoid cancer Wheezing Triple positive breast cancer Bladder cancer Advanced systemic mastocytosis Myasthenia gravis Hypoglycaemia Becker's muscular dystrophy Peripheral artery stenosis Giardiasis Ovarian cancer recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera di Padova

Azienda Ospedaliera di Padova

Via Nicolo' Giustiniani 2, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Golexanolone for Patients with Primary Biliary Cholangitis Experiencing Fatigue and Cognitive Dysfunction

    Not recruiting

    1 1
    Investigated Diseases:
    • Primary biliary cholangitis
    Investigated Drugs:
    • Golexanolone
    Germany Greece Hungary Italy Spain

  • Study on Imatinib and Chemotherapy Combination for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Crisantaspase
    • Hydrocortisone Sodium Succinate
    • Daunorubicin Hydrochloride
    Austria Belgium Czechia Denmark Finland France +6

  • Study on the Safety and Effectiveness of EHSG-KF for Treating Full-Thickness Skin Defects in Adults and Children

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Bilayer Engineered Collagen Hydrogel-Based Skin Graft Composed Of Autologous Keratinocytes And Fibroblasts
    Italy The Netherlands

  • Study on the Safety and Effectiveness of Hydroxypropylbetadex and Miglustat for Patients with Niemann-Pick Disease Type C1

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Niemann-Pick disease
    Investigated Drugs:
    • Hydroxypropylbetadex
    • Miglustat
    Germany Italy Poland Spain

  • Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Asundexian
    • Apixaban
    Austria Belgium Bulgaria Czechia Denmark Estonia +16

  • Study on the Effectiveness and Safety of Oral Azacitidine for Patients with Low or Intermediate-Risk Myelodysplastic Syndrome

    Not recruiting

    4 1
    Investigated Drugs:
    • Azacitidine
    Austria Czechia Denmark France Germany Greece +4

  • Study on Monkeypox Virus Disease: Effects of Tecovirimat in Patients with and without Antiviral Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Monkeypox
    Investigated Drugs:
    • Tecovirimat
    Belgium France Ireland Italy The Netherlands Norway +2

  • Long‑term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasal polyps: an extension study

    Not recruiting

    3 1
    Investigated Drugs:
    • Itepekimab
    Austria Belgium Czechia Denmark Finland France +9

  • Study of NIDO-361 for Patients with Spinal and Bulbar Muscular Atrophy (SBMA)

    Not recruiting

    2 1
    Investigated Diseases:
    • Bulbospinal muscular atrophy congenital
    Investigated Drugs:
    • Nido-361
    Denmark Italy

  • Study on Tafasitamab and Lenalidomide with Standard Therapy for Newly Diagnosed High-Risk Diffuse Large B-Cell Lymphoma Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Betamethasone Sodium Phosphate
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    Austria Czechia France Germany Hungary Ireland +5
Previous Page
1 … 39 40 41

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!